WHO IRISopen access
Guidelines on long-acting injectable cabotegravir for HIV prevention: web annex E: predicted effects of introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study
hiv infections, guidelines as topic, anti-hiv agents, pre-exposure prophylaxis, cabotegravir, africa south of the sahara, drug therapy, therapeutic use
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 376871
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.